FDA
-
-
-
-
-
-
-
Two peer-reviewed studies examine cryoablation's role in breast cancer care
-
-
-
-
-
-
-
IceCure Medical expands U.S. sales team after 70% install base growth
-
-
-
-
-
-
-
IceCure Medical reports 70% growth in U.S. install base for breast cryoablation
-
-
-
-
-
-
-
IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates
-
-
-
-
-
-
-
IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense® Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas
-
-
-
-
-
-
-
IceCure Celebrates American Society of Breast Surgeons' (ASBrS) Proposed Breast Cancer Treatment Guidelines Which Include Cryoablation for Low-Risk Breast Cancer
-
-
-
-
-
-
-
IceCure Receives Notice of Patent Allowance in China for a Novel Cryogen Flow Control to Optimize Patient Cryoablation Outcomes
-
334,289 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


